从地区上来看，欧洲和北美洲对工业酶制剂的需求量最大，需求占比合计近80%，而中国的需求量占比约为9.4%。
在酶制剂需求日益增长以及利好政策等推动下，2014年中国工业酶制剂产量已达116.57万吨。未来几年，中国工业酶产量将继续保持10%左右的速度增长，预计到2017年产量将达154.87万吨。
在引进国外先进设备、优良菌种、新型酶制剂的基础上，中国酶制剂工业得到迅猛发展，中国本土酶制剂企业也得到较快发展。目前，中国本土竞争实力相对较强的酶制剂生产企业包括溢多利、尤特尔、昕大洋、新华扬等。
溢多利是中国本土酶制剂龙头企业，拥有内蒙古溢多利和湖南鸿鹰生物（14年收购75%股权）两家子公司，公司产能达18.6万吨/年。2014年，其实现营业收入3.5982亿元，净利润为5513万元（不包含湖南鸿鹰生物营业收入）。目前，内蒙古溢多利的年产2万吨酶制剂项目、湖南鸿鹰生物年产14万吨酶制剂项目均已启动。
尤特尔在美国建有先进的菌种研发中心，在湖南、山东建有两个大型的发酵生产基地，年生产规模近8万吨，但公司产能利用率不高。2014年，尤特尔营业收入1.539亿元，净利润1074万元。
《2014-2017年全球及中国工业酶行业研究报告》包含以下内容：
全球工业酶行业发展概况，包括市场规模、竞争格局、需求结构；
中国工业酶行业发展概况，包括发展历程、政策环境、发展现状、进出品以及竞争格局；
中国酶制剂行业下游行业发展概况，包括食品行业、饲料行业、酿酒行业、洗涤行业、造纸行业、纺织行业；
国外4家、中国9家工业酶主要生产企业介绍，包括公司简介、经营情况及其工业酶业务等。
In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzyme market is basically an oligopoly. In 2014, Novozymes, an industrial enzyme giant, accounted for a 44% market share while that for Dupont and DSM was 20% and 6%, respectively.
Regionally, Europe and North America have the largest demand for industrial enzyme, occupying nearly 80% in sharp contrast to some 9.4% in China.
Stimulated by the growing demand for enzyme preparations and favorable policies, China's industrial enzyme preparation output reached 1.1657 million tons in 2014. For years to come, industrial enzyme output will keep 10% growth rate, to 1.5487 million tons by 2017.
By introducing foreign advanced equipment, excellent strains, and new-type enzyme preparations, China has scored rapid development of enzyme preparation industry, especially the Chinese enzyme preparation enterprises. Currently, the enterprises with strong competitive power in China include VTR Bio-Tech, Youtell Biochemical, Smistyle, SunHY, etc.
As an enzyme preparation leader in China, VTR Bio-Tech has two subsidiaries: VTR Bio-Tech (Inner Mongolia) and Hunan Hong Ying Xiang Biochemistry (acquiring a 75% stake in 2014), with an annual capacity of 186,000 tons. In 2014, the company recorded revenue of RMB359.82 million and net income of RMB55.13 million (excluding that of Hunan Hong Ying Xiang). At present, VTR Bio-Tech (Inner Mongolia)’s 20,000 tons/a enzyme preparation project and Hunan Hong Ying Xiang’s 140,000 tons/a enzyme preparation project have been jumpstarted.
Youtell boasts advanced R&D center in the United States and two large fermentation production bases in Hunan and Shandong, with the annual production scale approaching 80,000 tons but lower capacity utilization. In 2014, the company posted RMB153.9 million in revenue and RMB10.74 million in net income.
Global and China Enzyme Preparation Industry, 2014-2017 is all about the following:
Development of global industrial enzyme industry, including market size, competition pattern, and demand structure;
Development of China’s industrial enzyme industry, including development history, policy environment, development status, import and export, and competition pattern;
Development of downstream sectors of China’s enzyme preparation industry, including food, feedstuff, brewing, detergent, papermaking, and textile industries;
Four global and nine major Chinese industrial enzyme manufacturers, including their profile, operation, and their industrial enzyme business.
